These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15075)

  • 1. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA; Lippmann W
    J Pharm Pharmacol; 1977 Mar; 29(3):135-8. PubMed ID: 15075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract]   [Full Text] [Related]  

  • 9. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP; Grahame-Smith DG; Green AR; Tordoff AF
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute and chronic tri-iodothyronine (T3) administration to rats on central 5-HT and dopamine-mediated behavioural responses and related brain biochemistry.
    Atterwill CK
    Neuropharmacology; 1981 Feb; 20(2):131-44. PubMed ID: 7193809
    [No Abstract]   [Full Text] [Related]  

  • 11. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of citalopram (Lu 10-171) on tranylcypromine and tryptophan-induced wet-dog shakes in rats.
    Keshavan HJ; Gurbani NK; Dandiya PC
    Psychopharmacology (Berl); 1980; 70(2):209-12. PubMed ID: 6159662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats.
    Green AR; Grahame-Smith DG
    Nature; 1974 Oct; 251(5475):524-6. PubMed ID: 4214262
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan.
    Marsden CA; Curzon G
    Neuropharmacology; 1979 Feb; 18(2):159-64. PubMed ID: 431783
    [No Abstract]   [Full Text] [Related]  

  • 16. The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.
    Marsden CA; Curzon G
    Psychopharmacology (Berl); 1978 Apr; 57(1):71-6. PubMed ID: 149328
    [No Abstract]   [Full Text] [Related]  

  • 17. The concentration of 5-methoxytryptamine in rat brain and its effects on behaviour following its peripheral injection.
    Green AR; Hughes JP; Tordoff AF
    Neuropharmacology; 1975 Aug; 14(8):601-6. PubMed ID: 126386
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of L-tryptophan, L-3, 4, dihydroxyphenylalanine and tranylcypromine on the electroencephalogram and on photically induced epilepsy in the baboon, Papio papio.
    Meldrum BS; Balzamo E; Wada JA; Vuillon-Cacciuttolo G
    Physiol Behav; 1972 Oct; 9(4):615-21. PubMed ID: 4209277
    [No Abstract]   [Full Text] [Related]  

  • 19. Some observations on the behavioural and biochemical effects of L-tryptophan plus a monoamine oxidase inhibitor in immature rats [proceedings].
    Atterwill CK; Costain DW; Green AR
    Br J Pharmacol; 1979 May; 66(1):118P-119P. PubMed ID: 454914
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1974 Nov; 13(10-11):949-59. PubMed ID: 4437730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.